Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
29.2%Capital Expenditures to Operating Cash Flow
VS
Market
Sector
Industry
History
$ 6.06Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information
Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMUCELL CORP - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ICCC - CapEx/OCF Historical data
| Date | Capital Expenditure | Capital Expenditures to Operating Cash Flow | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ 739.61K | 29.2% | $ 2.53M |
| 3/31/2025 | $ 719.92K | 47.57% | $ 1.51M |
| 12/31/2024 | $ 461.23K | 128.87% | $ 357.9K |
| 9/30/2024 | $ 346.35K | 0% | $ -362.12K |
| 6/30/2024 | $ 676.07K | 0% | $ -230.54K |
| 3/31/2024 | $ 1.28M | 0% | $ -1.49M |
| 12/31/2023 | $ 1.89M | 0% | $ -4.67M |
| 9/30/2023 | $ 3.3M | 0% | $ -5.25M |
| 6/30/2023 | $ 3.62M | 0% | $ -6M |
| 3/31/2023 | $ 3.85M | 0% | $ -4.94M |
Key Performance Insights, Last 5 Years
- IMMUCELL CORP's latest trailing twelve months (TTM) CapEx/OCF stands at 384.53%.
- Over the past 5 years, IMMUCELL CORP's average CapEx/OCF has been 281.03%.
- The median CapEx/OCF for IMMUCELL CORP during this period was 219.67%
- IMMUCELL CORP reached its highest CapEx/OCF over the past 5 years at 929.48%.
- The lowest CapEx/OCF recorded by IMMUCELL CORP in the same timeframe 29.2%
Similar metrics to CF - Operations:
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
Definition of Capital Expenditures to Operating Cash Flow
[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].CapEx / CF - Operations
(=) CapEx/OCF CapEx/OCF for IMMUCELL CORP is calculated as follows: CapEx [ $ 4.28M ] / CF - Operations [ $ 1.11M ]
(=) CapEx/OCF [ 384.53% ] ICCC - Capital Expenditures to Operating Cash Flow, Last 5 years
29.2%
Minimum
Jun 30, 2025
929.48%
Maximum
Sep 30, 2022
281.03%
Average
219.67%
Median
CapEx/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.82% with a standard deviation of 29.54%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
| filtered constituents | 2.35K |
|---|---|
| min | 0.01% |
| max | 128% |
| average | 31.82% |
| median | 22.41% |
| std | 29.54% |